
Morning RX: June 7, 2023
Cue Health gets FDA’s first de novo approval for at-home COVID-19 test, Novavax says its new vaccine will fight new variants and HHS creates new cert standards for peer support workers.
Cue Health Gets FDA’s First Regular-Use Clearance For At-Home COVID-19 Test
Healthcare tech company Cue Health has received marketing authorization from the FDA for its at-home COVID-19 test, the
“Today’s authorization is the first at-home COVID-19 test granted marketing authorization outside of emergency use authorities, representing a new era of consumer access to diagnostic tests that can be performed entirely at home,” Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health,
Novavax’s New COVID-19 Vaccine Should be Effective Against Latest Variants
A COVID-19 vaccine being produced by biotech company Novavax should be protective against any variants that are currently on the rise, Filip Dubovsky, head of research and development at Novavax,
HHS Publishes Certification Standards for Peer Support Workers
The US Department of Health and Human Services has published national model standards for substance use, mental health, and family peer workers. The
Related to this article








